Chromosomal Microarray Analysis for DD/ID (Cyto-400+)
Phalanx Biotech collaborated with clinicians and genetic medicine experts in the design and development of pediatric chromosomal microarray to detect DNA microamplification and microdeletions within the full genome. This one microarray provides screening for 400+ hereditary disorders arising from CNVs, and features excellent discriminative power and sensitivity.
Two primary mutations in human genome
Five genetic factors of developmental delay
Integrated genetic disorder testing service
By combining the advantages of “Chromosomal Microarray Analysis for DD/ID (Cyto-400+)” and “Whole Exome Sequencing (WES) for DD/ID”, it is possible to conduct efficient investigation on the cause of disorders including CNVs and SNVs. The result of analysis supports the physician in determining the condition and providing the best management.
Genetic disease testing
- Individuals with clinical manifestation, for example, developmental delay or intellectual disability, who is not otherwise diagnosed.
- Unknown cause, unable to be specified via clinical means, seeks to rule out the possibilities of gene abnormality.
- Familial history of births with other genetic disorder, chromosomal disorder or congenital defect.